Complex regional pain syndrome type I in children

Related Experiment Video

Updated: Jul 6, 2026

Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
07:12

Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats

Published on: January 21, 2020

Edward C T H Tan1, Basil Zijlstra, Marlou L Essink

  • 1Department of General Surgery-Traumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. e.tan@chir.umcn.nl

Acta Paediatrica (Oslo, Norway : 1992)
|April 16, 2008
PubMed

Insights

Complex Regional Pain Syndrome type I (CRPS I) presents differently in children compared to adults. Pediatric CRPS I often involves cooler extremities, more lower limb involvement, and fewer neurological symptoms.

Area of Science:

  • Pediatric Pain Medicine
  • Neurology
  • Rheumatology

Background:

  • Complex Regional Pain Syndrome type I (CRPS I) is a debilitating condition following minor trauma.
  • While recognized in adults, CRPS I in children is a less understood diagnostic entity.
  • Pediatric CRPS I presentation can differ from adults, potentially delaying diagnosis.

Purpose of the Study:

  • To investigate and identify key differences in patient characteristics between pediatric and adult CRPS I cases.
  • To improve early recognition and management of CRPS I in children.

Main Methods:

  • A retrospective chart review was conducted.
  • Data from 78 children (age ≤16 years) with CRPS I were analyzed.
  • This cohort was compared against a larger group of 951 adult CRPS I patients.

Main Results:

  • The pediatric cohort was predominantly female, with a median age of 13 years.
  • Children more frequently presented with cooler skin temperature in the affected limb.
  • Lower extremity involvement was more common in children, with less pronounced neurological and sympathetic symptoms.

Conclusions:

  • CRPS I exhibits distinct clinical features in children compared to adults.
  • Understanding these differences is crucial for accurate pediatric diagnosis and treatment.
Abstract

More Related Videos

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...